INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Revenue (Quarterly): 1.382M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.382M |
| September 30, 2023 | 0.9749M |
| June 30, 2023 | 0.3159M |
| March 31, 2023 | 0.348M |
| December 31, 2022 | 0.2781M |
| September 30, 2022 | 0.2353M |
| June 30, 2022 | 0.1461M |
| March 31, 2022 | 0.1626M |
| December 31, 2021 | 3.048M |
| September 30, 2021 | 0.2189M |
| June 30, 2021 | 0.2085M |
| March 31, 2021 | 0.6845M |
| December 31, 2020 | 0.1966M |
| September 30, 2020 | 0.3361M |
| June 30, 2020 | 0.2461M |
| March 31, 2020 | 0.2586M |
| December 31, 2019 | 0.3286M |
| September 30, 2019 | 0.3036M |
| June 30, 2019 | 0.6586M |
| March 31, 2019 | 0.1894M |
| December 31, 2018 | 0.155M |
| September 30, 2018 | 0.125M |
| June 30, 2018 | 0.1102M |
| March 31, 2018 | 0.1041M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0814M |
| September 30, 2017 | 0.0682M |
| June 30, 2017 | 0.0803M |
| March 31, 2017 | 0.0522M |
| December 31, 2016 | 0.0095M |
| September 30, 2016 | 0.0178M |
| June 30, 2016 | 0.0054M |
| March 31, 2016 | 0.0181M |
| December 31, 2015 | |
| September 30, 2015 | 0.0025M |
| June 30, 2015 | 0.0056M |
| March 31, 2015 | 0.0036M |
| December 31, 2011 | 0.0038M |
| September 30, 2011 | 0.0129M |
| June 30, 2011 | 0.0218M |
| March 31, 2011 | 0.0331M |
| December 31, 2010 | 0.0297M |
| September 30, 2010 | |
| June 30, 2010 | 0.0112M |
| March 31, 2010 | 0.0268M |
| December 31, 2009 | 0.0069M |
| September 30, 2009 | 0.0029M |
| June 30, 2009 | 0.0166M |
| March 31, 2009 | 0.0368M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.1461M
Minimum
Jun 2022
3.048M
Maximum
Dec 2021
0.5437M
Average
0.3036M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 9.964B |
| Perspective Therapeutics Inc | -5.239M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
| Catheter Precision Inc | 0.128M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.995M |
| Total Expenses (Quarterly) | 2.890M |
| EPS Diluted (Quarterly) | -0.8003 |
| Enterprise Value | 11.07M |
| Gross Profit Margin (Quarterly) | 35.82% |
| Profit Margin (Quarterly) | -144.4% |
| Earnings Yield | -925.5% |
| Normalized Earnings Yield | -916.81 |